Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Clinical Trials

Alexion Announces Topline Results from Phase 3 REGAIN Study of Eculizumab

Clinical Trials
Alexion Pharmaceuticals, Inc announced topline results from the REGAIN study, a Phase 3 registration trial of eculizumab (Soliris®) in patients with refractory generalized myasthenia...

Kyowa Hakko Kirin Announces Phase 2 Clinical Study of RTA 402 in CKD patients with type 2 diabetes in Japan

Clinical Trials
Bardoxolone Methyl (RTA 402) Data Show Improvement in Renal Function by Inulin Clearance in a Phase II Clinical Study in Japan Kyowa Hakko Kirin...

Spark Therapeutics, Pfizer announce data from initial subjects in hemophilia B trial

Clinical Trials
Subjects received one-time administration of a highly optimized gene therapy at initial low dose without the need for immunosuppression Therapeutic Factor IX activity...

Chugai set to present Alecensa’s Japanese phase III results at ASCO

Clinical Trials
Chugai Pharmaceutical Co Ltd announced that the results of the Japanese phase III study (J-ALEX) of Alecensa®, in ALK fusion gene positive non-small cell...

AstraZeneca reports positive results from benralizumab phase III programme

Clinical Trials
AstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated and achieved the primary endpoint in two pivotal Phase...

Benralizumab first AstraZeneca respiratory biologic to complete Phase III

Clinical Trials
AstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated and achieved the primary endpoint in two pivotal Phase...

Mallinckrodt begins patient enrollment in phase 4 study of HP Acthar gel for rare cause of nephrotic syndrome

Clinical Trials
Mallinckrodt plc a leading global specialty biopharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4 clinical study assessing the...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.